Business Description
Fuso Pharmaceutical Industries Ltd
ISIN : JP3823600006
Total Employee Number:
1,340Description
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 5.29 | |||||
Interest Coverage | 8.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.2 | |||||
Beneish M-Score | -2.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.9 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year Book Growth Rate | 0.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.73 | |||||
9-Day RSI | 61.89 | |||||
14-Day RSI | 59.96 | |||||
3-1 Month Momentum % | -11.31 | |||||
6-1 Month Momentum % | -13.78 | |||||
12-1 Month Momentum % | -2.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 119.45 | |||||
Days Sales Outstanding | 148.84 | |||||
Days Payable | 32.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.21 | |||||
Dividend Payout Ratio | 0.39 | |||||
3-Year Dividend Growth Rate | 8.7 | |||||
Forward Dividend Yield % | 4.21 | |||||
5-Year Yield-on-Cost % | 6.36 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -49.19 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.67 | |||||
Operating Margin % | 4.24 | |||||
Net Margin % | 3.23 | |||||
EBITDA Margin % | 8.64 | |||||
FCF Margin % | -12.65 | |||||
OCF Margin % | -9.99 | |||||
ROE % | 5.91 | |||||
ROA % | 2.34 | |||||
ROIC % | 2.91 | |||||
3-Year ROIIC % | 2.85 | |||||
ROC (Joel Greenblatt) % | 6.09 | |||||
ROCE % | 7.26 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.08 | |||||
PE Ratio without NRI | 9.38 | |||||
Shiller PE Ratio | 20.6 | |||||
PS Ratio | 0.3 | |||||
PB Ratio | 0.53 | |||||
Price-to-Tangible-Book | 0.54 | |||||
EV-to-EBIT | 15.14 | |||||
EV-to-EBITDA | 7.77 | |||||
EV-to-Revenue | 0.67 | |||||
EV-to-FCF | -5.33 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 1.15 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Price-to-Graham-Number | 0.48 | |||||
| Price-to-Net-Current-Asset-Value | 8.83 | |||||
Earnings Yield (Greenblatt) % | 6.6 | |||||
FCF Yield % | -43.15 | |||||
Forward Rate of Return (Yacktman) % | 10.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fuso Pharmaceutical Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 62,307 | ||
| EPS (TTM) (円) | 235.621 | ||
| Beta | 0.0178 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 18.63 | ||
| 14-Day RSI | 59.96 | ||
| 14-Day ATR (円) | 30.098822 | ||
| 20-Day SMA (円) | 2101.1 | ||
| 12-1 Month Momentum % | -2.67 | ||
| 52-Week Range (円) | 1990 - 2530 | ||
| Shares Outstanding (Mil) | 8.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fuso Pharmaceutical Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fuso Pharmaceutical Industries Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| JPY 45.000000 Cash Dividend | 2026-09-29 | In 77 days | ||
| JPY 45.000000 Cash Dividend | 2026-03-30 | 2,424.00 (+1.00%) | ||
| JPY 45.000000 Cash Dividend | 2025-09-29 | 2,192.00 (+0.60%) | ||
| JPY 42.000000 Cash Dividend | 2025-03-28 | 2,577.00 (-0.23%) | ||
| JPY 40.000000 Cash Dividend | 2024-09-27 | 2,319.00 (+0.91%) | ||
| 0.1:1 Stock Split | 2016-09-28 | 2,860.00 (+1.42%) |
Show
Entries
Fuso Pharmaceutical Industries Ltd Frequently Asked Questions
What is Fuso Pharmaceutical Industries Ltd(TSE:4538)'s stock price today?
The current price of TSE:4538 is 円2140.00. The 52 week high of TSE:4538 is 円2530.00 and 52 week low is 円1990.00.
When is next earnings date of Fuso Pharmaceutical Industries Ltd(TSE:4538)?
The next earnings date of Fuso Pharmaceutical Industries Ltd(TSE:4538) is .
Does Fuso Pharmaceutical Industries Ltd(TSE:4538) pay dividends? If so, how much?
The Dividend Yield %  of Fuso Pharmaceutical Industries Ltd(TSE:4538) is 4.21% (As of Today), Highest Dividend Payout Ratio of Fuso Pharmaceutical Industries Ltd(TSE:4538) was 1.48. The lowest was 0.28. And the median was 0.41. The  Forward Dividend Yield % of Fuso Pharmaceutical Industries Ltd(TSE:4538) is 4.21%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Fuso Pharmaceutical Industries Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers